“…Of the 12 eligible studies, 2 studies were from North America [8,22], 3 from Europe [10,15,23], and 7 from Asia [12,14,16,20,21,24,25]. Five studies [12,16,22,23,25] included pediatric patients only, others included pediatric and adult patients [8,[13][14][15]20,21,23,24]. All the patients in the 12 studies were treated by IST, but therapy information was not available in 2 studies [15,25].…”